Journal of Bionic Engineering ›› 2022, Vol. 19 ›› Issue (4): 1109-1123.doi: 10.1007/s42235-022-00191-3

• • 上一篇    

A Novel Method to Improve the Physical Property and Biocompatibility of Decellularized Heart Valve Scaffold with Sericin and Polydopamine

Peng Bai1, Gangcheng Kong2, Weihua Qiao1, Yu Song3, Yixuan Wang1, Jiawei Shi1, Nan Zhang4, Chungeng Liu1, Chong Chu1, Tixiusi Xiong1, Ying Zhou1, Cuifen Lu5, Lin Wang3,6, Nianguo Dong1   

  1. 1 Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430032, China  2 Department of Hepatobiliary and Pancreatic Surgery, The First Afliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China  3 Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China  4 Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430032, China  5 Collaborative Innovation Center for Advanced Organic Chemical Materials Co-constructed by the Province and Ministry, Hubei University, Wuhan 430062, China  6 Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
  • 收稿日期:2021-10-02 修回日期:2022-03-21 接受日期:2022-03-24 出版日期:2022-09-22 发布日期:2022-09-23
  • 通讯作者: Lin Wang, Nianguo Dong E-mail:lin_wang@hust.edu.cn, 1986XH0694@hust.edu.cn
  • 作者简介:Peng Bai1, Gangcheng Kong2, Weihua Qiao1, Yu Song3, Yixuan Wang1, Jiawei Shi1, Nan Zhang4, Chungeng Liu1, Chong Chu1, Tixiusi Xiong1, Ying Zhou1, Cuifen Lu5, Lin Wang3,6, Nianguo Dong1

A Novel Method to Improve the Physical Property and Biocompatibility of Decellularized Heart Valve Scaffold with Sericin and Polydopamine

Peng Bai1, Gangcheng Kong2, Weihua Qiao1, Yu Song3, Yixuan Wang1, Jiawei Shi1, Nan Zhang4, Chungeng Liu1, Chong Chu1, Tixiusi Xiong1, Ying Zhou1, Cuifen Lu5, Lin Wang3,6, Nianguo Dong1   

  1. 1 Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430032, China  2 Department of Hepatobiliary and Pancreatic Surgery, The First Afliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China  3 Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China  4 Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430032, China  5 Collaborative Innovation Center for Advanced Organic Chemical Materials Co-constructed by the Province and Ministry, Hubei University, Wuhan 430062, China  6 Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
  • Received:2021-10-02 Revised:2022-03-21 Accepted:2022-03-24 Online:2022-09-22 Published:2022-09-23
  • Contact: Lin Wang, Nianguo Dong E-mail:lin_wang@hust.edu.cn, 1986XH0694@hust.edu.cn
  • About author:Peng Bai1, Gangcheng Kong2, Weihua Qiao1, Yu Song3, Yixuan Wang1, Jiawei Shi1, Nan Zhang4, Chungeng Liu1, Chong Chu1, Tixiusi Xiong1, Ying Zhou1, Cuifen Lu5, Lin Wang3,6, Nianguo Dong1

摘要: Cardiac valve replacement is an effective method to treat valvular heart disease. Artificial valves used routinely in clinic still have defects. In our study, we explored a novel method to modify the performance of Decellularized Heart Valve (DHV) scaffold. The decellularized porcine aortic valve was prepared using sequential hydrophile and lipophile solubilization method. The sericin was extracted from silk fibroin-deficient silkworm cocoon by lithium bromide method. First, DHV was immersed in sericin solution to produce the sericin–DHV composite scaffold. Then, we modified the DHV by making a Polydopamine (PDA) coating on the DHV first and then binding the sericin. The physical properties and biological compatibility of our composite scaffold were assessed in vitro and in vivo. Sericin were successfully prepared, combined to DHV and improved its biocompatibility. PDA coating further promoted the combination of sericin on DHV and improved the physical properties of scaffolds. The decay rate of our modified valve scaffold was decreased in vivo and it showed good compatibility with blood. In conclusion, our modification improved the physical properties and biocompatibility of the valve scaffold. The combination of PDA and sericin promoted the recellularization of decellularized valves, showing great potential to be a novel artificial valve.

关键词: Decellularized heart valve , · Sericin , · Polydopamine , · Biocompatibility

Abstract:

Cardiac valve replacement is an effective method to treat valvular heart disease. Artificial valves used routinely in clinic still have defects. In our study, we explored a novel method to modify the performance of Decellularized Heart Valve (DHV) scaffold. The decellularized porcine aortic valve was prepared using sequential hydrophile and lipophile solubilization method. The sericin was extracted from silk fibroin-deficient silkworm cocoon by lithium bromide method. First, DHV was immersed in sericin solution to produce the sericin–DHV composite scaffold. Then, we modified the DHV by making a Polydopamine (PDA) coating on the DHV first and then binding the sericin. The physical properties and biological compatibility of our composite scaffold were assessed in vitro and in vivo. Sericin were successfully prepared, combined to DHV and improved its biocompatibility. PDA coating further promoted the combination of sericin on DHV and improved the physical properties of scaffolds. The decay rate of our modified valve scaffold was decreased in vivo and it showed good compatibility with blood. In conclusion, our modification improved the physical properties and biocompatibility of the valve scaffold. The combination of PDA and sericin promoted the recellularization of decellularized valves, showing great potential to be a novel artificial valve.

Key words: Decellularized heart valve , · Sericin , · Polydopamine , · Biocompatibility